Tyra Bio rises on upcoming mid-stage trial readout for bladder cancer drug
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think similar experimental medicines can succeed.
The race to make new Ebola vaccines faces a cash crunch
A rapidly growing outbreak of Ebola in Africa has prompted a race to develop new vaccines against the virus, even as a crucial organization spearheading the effort is low on funds.
Uganda: How C-Care Uganda Rallied Behind Thousands At the 2026 Rotary Cancer Run
[Independent (Kampala)] Kampala -- At the weekend, C-Care Uganda once again joined the Rotary Cancer Run as a key healthcare partner, bringing its medical expertise closer to participants and…
- C-Care Uganda provided medical support at 2026 Rotary Cancer Run.
- Dr Miriam Mutero Musinga highlighted partnership's healthcare mission.
- Run aimed to raise UGX 5 billion for cancer treatment center.
PTA hands over ultramodern infirmary to improve healthcare at Nkoranman SHS
The Parent-Teacher Association (PTA) of Nkoranman Senior High School at Seikwa in the Bono Region has constructed and handed over an ultramodern infirmary to improve access to basic healthcare for…
Women’s health: Why early screening matters, even without symptoms
Health experts at the inaugural Women’s Health Matters Conference 2026 urged women to prioritise routine screening and early detection, even when they feel healthy.
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
The drugmaker is leaning on a better side effect profile compared to drugs from J&J, Pfizer and Regeneron as it pushes etentamig toward FDA submission.